Lansoprazole 30 mg DR Capsule Replicate Food Study
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The object of this study is to compare the relative bioavailability of lansoprazole 30 mg
delayed-release capsules (manufactured by TEVA Pharmaceutical Industries, Ltd. and
distributed by TEVA Pharmaceuticals USA) with that of PREVACID® capsules (TAP
Pharmaceuticals, Inc.) in healthy, adult, subjects under non-fasting conditions.